MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Clinical trials for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS trials appear
Sign up with your email to follow new studies for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study seeks best test for rare brain disease
Diagnosis Recruiting nowThis study aims to find the best way to diagnose MOG antibody disease, a rare autoimmune condition that affects the brain and nerves. Researchers will compare two lab tests (live-cell and fixed-cell) in 240 adults suspected of having the disease. The goal is to see which test is …
Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Sponsor: Huashan Hospital • Aim: Diagnosis
Last updated May 26, 2026 09:09 UTC
-
New study to uncover how MS and its treatments affect pregnancy and child health
Knowledge-focused Recruiting nowThis study is a national registry that follows 1,500 women with multiple sclerosis (MS) or related conditions during pregnancy and after childbirth, along with their children. Researchers aim to learn how the disease and medications impact pregnancy, breastfeeding, and long-term …
Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 26, 2026 09:08 UTC